The global atenolol tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atenolol is a beta-blocker drug used to treat excessive blood pressure and chest discomfort caused by the heart. However, atenolol does not appear to reduce mortality in people with high blood pressure. Other applications include migraine prophylaxis and the therapy of certain irregular heartbeats. The major factor driving the demand for atenolol tablets is the new product and treatment launch in atenolol tablets to control high blood pressure, chest pain, irregular heartbeat, among others across the globe.
For instance, in November 2020, Unichem Laboratories announced that the United States Food and Drug Administration (USFDA) has given its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg ANDA approval to market a common version of Alvogen Malta Operations’ TENORETIC (atenolol and chlorthalidone) Tablets. Tablets containing atenolol and chlorthalidone are used to treat hypertension and lower blood pressure. Unichem’s Ghaziabad factory will commercialize the product.
Some major players in the market include AstraZeneca plc, Aceto Co., Aurobindo Pharma Ltd., Sandoz International GmbH, Mylan N.V., among others. The market players are serving significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance, in July 2019, Rising Pharmaceuticals, ACETO Corp.’s final dosage form generics subsidiary launched Atenolol Tablets 25mg, 50mg, and 100mg, an FDA-approved generic version of Alvogen Malta Operations Ltd.’s reference listed medication, TENORMIN, which is intended for hypertension.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Balsalazide Market athttps://orionmarketreports.com/request-sample/?id=92676&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– AstraZeneca plc, Aceto Co., Aurobindo Pharma Ltd., Sandoz International GmbH, Mylan N.V., among others.
A full report is available at: https://orionmarketreports.com/global-atenolol-tablets-market/92676/
Global Atenolol Tablets Market Report by Segment
By Type
- 25mg
- 50mg
- 100mg
By Application
- Hypertension
- Angina
- Arrhythmias
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
